Results 311 to 320 of about 4,106,951 (336)
Some of the next articles are maybe not open access.
Biomarkers of neuroendocrine tumors
Annales de biologie clinique, 2016Neuroendocrine tumors (NET) are rare heterogenous tumors which prevalence is increasing. Their features vary by anatomical location, functionality and hormonal production. Their management needs a multidisciplinary approach. Functional tumors develop characteristic clinical syndromes in contrast to non-functional tumors that are diagnosed fortuitously ...
Michèle d’Herbomez +5 more
openaire +2 more sources
International Journal of Oncology, 1996
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D Shin, W Hong
openaire +3 more sources
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D Shin, W Hong
openaire +3 more sources
, 2020
Accurate detection of multiple tumor biomarkers in clinical samples is critical for the early detection and treatment of cancers. Herein, we proposed a novel surface-enhanced Raman scattering (SERS)-based lateral flow immunoassay (LFIA) for the ultra ...
Wanzhu Shen +8 more
semanticscholar +1 more source
Accurate detection of multiple tumor biomarkers in clinical samples is critical for the early detection and treatment of cancers. Herein, we proposed a novel surface-enhanced Raman scattering (SERS)-based lateral flow immunoassay (LFIA) for the ultra ...
Wanzhu Shen +8 more
semanticscholar +1 more source
MRI biomarkers in osseous tumors
Journal of Magnetic Resonance Imaging, 2019Although radiography continues to play a critical role in osseous tumor assessment, there have been remarkable advances in cross‐sectional imaging. MRI has taken a lead in this assessment due to high tissue contrast and spatial resolution, which are well suited for bone lesion assessment.
Takeshi Fukuda +4 more
openaire +2 more sources
MicroRNAs as Biomarkers in Pituitary Tumors
Neurosurgery, 2014The use of extracellular microRNAs (miRNAs) as circulating biomarkers is currently leading to relevant advances in the diagnosis and assessment of prognosis of several diseases. Specific miRNAs have also been shown to play a role in the pathophysiology of many neoplastic and non-neoplastic diseases.
Michael D. Cusimano +8 more
openaire +3 more sources
Analytical Chemistry, 2019
Simultaneous detection of multiple tumor biomarkers is in great demand for early and accurate cancer diagnosis. A homogeneous electrochemical biosensor has been proven to possess high sensitivity, but achieving simultaneous detection of multiple tumor ...
Jiafu Chang +4 more
semanticscholar +1 more source
Simultaneous detection of multiple tumor biomarkers is in great demand for early and accurate cancer diagnosis. A homogeneous electrochemical biosensor has been proven to possess high sensitivity, but achieving simultaneous detection of multiple tumor ...
Jiafu Chang +4 more
semanticscholar +1 more source
Survivin: A promising tumor biomarker
Cancer Letters, 2007Survivin is a 16.5 kDa protein overexpressed in almost all malignancies but rarely detected in normal differentiated adult tissues. Functionally, survivin has been shown to inhibit apoptosis, promote cell proliferation and enhance angiogenesis. Consistent with its role in these processes, survivin has been shown to play a key role in cancer progression.
Bríd M. Ryan +4 more
openaire +3 more sources
The Role of CTCs as Tumor Biomarkers
2015Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challenging.
Evi Lianidou +2 more
openaire +3 more sources
2007
This chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.
Manfred Schmitt +5 more
openaire +2 more sources
This chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.
Manfred Schmitt +5 more
openaire +2 more sources